Home
>
US Stocks
>
Spruce Biosciences Inc
Spruce Biosciences Inc
SPRB

Spruce Biosciences Inc (SPRB)

$4.728.01%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$4.63
Today Low/High$4.63 / $4.72
52 Week Low/High$4.25 / $35.6
Market Cap$106.13M

Company Details

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess, representing 3-5% of females with PCOS (estimated to be 150,000 to 200,000 patients in the United States).
OrganisationSpruce Biosciences Inc
Employees17
IndustryCommercial Services

Discover more

Frequently Asked Questions

What is Spruce Biosciences Inc (SPRB) share price today?

Can Indians buy Spruce Biosciences Inc (SPRB) shares?

How can I buy Spruce Biosciences Inc (SPRB) shares from India?

Can Fractional shares of Spruce Biosciences Inc (SPRB) be purchased?

What are the documents required to start investing in Spruce Biosciences Inc (SPRB) stocks?

We are a SEBI registered investement advisor